* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected to show a
rise in quarterly revenue when it reports results on October
28.
* The Burlington, Massachusetts-based company is expected to
report a 7.2% increase in revenue to $39.046 million from
$36.42 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for LeMaitre Vascular Inc
is for earnings of 33 cents per share. For the same quarter last
year, the company reported earnings of 37 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular Inc is $65, about 15.1% above its last closing price
of $55.16.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 0.35 0.34 0.40 Beat 18.2
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
Dec. 31 2020 0.30 0.29 0.34 Beat 15.9
Sep. 30 2020 0.20 0.19 0.37 Beat 90.7
Jun. 0.00 0.01 0.21 Beat 3,048.
30 2020 4
Mar. 31 2020 0.16 0.15 0.16 Beat 4.4
Dec. 31 2019 0.23 0.23 0.23 Met 1.3
Sep. 30 2019 0.21 0.21 0.25 Beat 19.9
This summary was machine generated October 27 at 10:08 GMT. All
figures in US dollars unless otherwise stated